0001230439-23-000006.txt : 20230628 0001230439-23-000006.hdr.sgml : 20230628 20230628170157 ACCESSION NUMBER: 0001230439-23-000006 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230628 DATE AS OF CHANGE: 20230628 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Disc Medicine, Inc. CENTRAL INDEX KEY: 0001816736 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851613057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39438 FILM NUMBER: 231053040 BUSINESS ADDRESS: STREET 1: 300 ONE KENDALL SQUARE, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (617) 401-4400 MAIL ADDRESS: STREET 1: 300 ONE KENDALL SQUARE, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Gemini Therapeutics, Inc. /DE DATE OF NAME CHANGE: 20210209 FORMER COMPANY: FORMER CONFORMED NAME: FS Development Corp. DATE OF NAME CHANGE: 20200702 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Novo Holdings A/S CENTRAL INDEX KEY: 0001388325 IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 BUSINESS ADDRESS: STREET 1: TUBORG HAVNEVEJ 19 CITY: HELLERUP STATE: G7 ZIP: 2900 BUSINESS PHONE: 45 8824 8824 MAIL ADDRESS: STREET 1: TUBORG HAVNEVEJ 19 CITY: HELLERUP STATE: G7 ZIP: 2900 FORMER COMPANY: FORMER CONFORMED NAME: Novo A/S DATE OF NAME CHANGE: 20070130 144 1 primary_doc.xml 144 0001388325 XXXXXXXX LIVE 0001816736 Disc Medicine, Inc. 001-39438 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400 Novo Holdings A/S 10% Stockholder Common Stock BofA Securities, Inc.

One Bryant Park, 5th Floor New York NY 10036

1250000 62375000.00 22591161 06/28/2023 NASDAQGM Common Stock 09/12/2019 Private Purchase then exchange in merger Issuer N 548000 09/12/2019 Cash then exchange in merger Common Stock 05/01/2020 Private Purchase then exchange in merger Issuer N 730666 05/01/2020 Cash then exchange in merger Y 06/28/2023 /s/ Barbara Fiorini Due, General Counsel, Finance & Operations